No CrossRef data available.
Article contents
Home-inhaled nitric oxide in a child with pulmonary arterial hypertension associated with post-operative pulmonary venous obstruction
Published online by Cambridge University Press: 17 October 2023
Abstract
Home-inhaled nitric oxide therapy was effective and feasible in the patients with intractable pulmonary arterial hypertension. We present the case of a child with severe pulmonary arterial hypertension associated with post-operative pulmonary venous obstruction who was treated with home-inhaled nitric oxide therapy.
Keywords
- Type
- Brief Report
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press
References
Tominaga, Y, Iwai, S, Yamauchi, S, et al. Post-extubation inhaled nitric oxide therapy via high-flow nasal cannula after fontan procedure. Pediatr Cardiol 2019; 40: 1064–1071. DOI: 10.1007/s00246-019-02122-2.CrossRefGoogle ScholarPubMed
Seale, AN, Uemura, H, Webber, SA, et al. Total anomalous pulmonary venous connection: outcome of postoperative pulmonary venous obstruction. J Thorac Cardiovasc Surg 2013; 145: 1255–1262. DOI: 10.1016/j.jtcvs.2012.06.031.CrossRefGoogle ScholarPubMed
Yamaki, S, Tsunemoto, M, Shimada, M, et al. Quantitative analysis of pulmonary vascular disease in total anomalous pulmonary venous connection in sixty infants. J Thorac Cardiovasc Surg 1992; 104: 728–735.CrossRefGoogle ScholarPubMed
Humbert, M, Kovacs, G, Hoeper, MM, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2022; 30: 2200879. DOI: 10.1183/13993003.00879-2022.Google Scholar
Zhang, L, Wang, Y, Zhang, R. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: a case report. Medicine (Baltimore) 2021; 100: e27334. DOI: 10.1097/MD.0000000000027334.CrossRefGoogle ScholarPubMed
Van Duin, RWB, Stam, K, Uitterdijk, A, et al. Intervening with the nitric oxide pathway to alleviate pulmonary hypertension in pulmonary vein stenosis. J Clin Med 2019; 8: 1204. DOI: 10.3390/jcm8081204.CrossRefGoogle ScholarPubMed
Patel, JD, Briones, M, Mandhani, M, et al. Systemic sirolimus therapy for infants and children with pulmonary vein stenosis. J. Am Coll Cardiol 2021; 77: 2807–2818. DOI: 10.1016/j.jacc.2021.04.013.CrossRefGoogle ScholarPubMed
Zamanian, RT, Pollack, CV Jr, Gentile, MA, et al. Outpatient inhaled nitric oxide in a patient with vasoreactive idiopathic pulmonary arterial hypertension and COVID-19 infection. Am J Respir Crit Care Med 2020; 202: 130–132. DOI: 10.1164/rccm.202004-0937LE.CrossRefGoogle Scholar
Channick, RN, Newhart, JW, Johnson, FW, et al. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest 1996; 109: 1545–1549. DOI: 10.1378/chest.109.6.1545.CrossRefGoogle ScholarPubMed
Ivy, DD, Parker, D, Doran, A, Parker, D, Kinsella, JP, Abman, SH. Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension. Am J Cardiol 2003; 92: 886–890. DOI: 10.1016/s0002-9149(03)00910-x.CrossRefGoogle Scholar